• Kotaro Kameyama, Norihito Okumura, Etsuo Miyaoka, Hisao Asamura, Ichiro Yoshino, Hirohito Tada, Yoshitaka Fujii, Yoichi Nakanishi, Kenji Eguchi, Masaki Mori, Hideo Kobayashi, Noriyoshi Sawabata, Meinoshin Okumura, Kohei Yokoi, and Japanese Joint Committee of Lung Cancer Registry.
• Department of Thoracic Surgery, Kurashiki Central Hospital, Kurashiki, Japan. Electronic address: kk8724@kchnet.or.jp.
• J. Thorac. Cardiovasc. Surg.. 2014 Dec 1;148(6):2659-64.

ObjectiveAlthough positive pleural lavage cytology (PLC) has been demonstrated to be closely associated with a poor prognosis for patients with lung cancer, it has not been incorporated into the TNM staging system of the Union for International Cancer Control. The aim of our study was to retrospectively examine the clinical significance of PLC status and illustrate the recommendations of the International Pleural Lavage Cytology Collaborators (IPLCC) in a large national database.MethodsThe Japanese Joint Committee of Lung Cancer Registry database included 11,073 patients with non-small cell lung cancer who underwent resections in 2004. We extracted the clinicopathologic data for 4171 patients (37.3%) who underwent PLC. These patients were staged according to the seventh edition of the Union for International Cancer Control TNM classification and by recommendations of the IPLCC, in which T was singly upgraded up to a maximum of T4 for those who were PLC-positive. Prognoses based on these 2 systems were compared.ResultsA total of 217 patients (5.2%) were PLC-positive, which was significantly associated with a higher incidence of adenocarcinoma and advanced disease. The 5-year survival for patients with positive and negative PLC results were 44.5% and 72.8%, respectively, and this difference in survival was statistically significant (P < .001). Multivariate analysis showed that positive PLC status was an independent factor for a poor prognosis (hazard ratio, 1.57; P < .001). Significant differences in survival were also found between patients with positive and negative PLC results in the same T categories and stages, including T2a, T3, stage IB, and stage IIIA. The IPLCC recommendations adjusted the prognostic differences in all T categories and stages. The significant difference in survival disappeared between the 2 groups in all T categories and stages.ConclusionsOur results indicate that a T category upgrade is prognostically adequate for patients who are PLC-positive.Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

34 keywords...

hide…